Ebola virus exploits host enzyme for efficient entry to target cells

February 7, 2018, Hokkaido University
The ebolavirus-like particle generated to investigate the mechanisms of Ebola virus entry. Credit: Nanbo A. et al., PLoS Pathogens, January 16, 2018

Researchers have identified a key process that enables the deadly Ebola virus to infect host cells, providing a novel target for developing antiviral drugs. The Ebola virus incorporates a cellular enzyme into its virus particles, facilitating the infection to the target cells, according to new research published in the journal PLOS Pathogens.

When this enzyme Xkr8 is activated, it flips a phospholipid called phosphatidylserine (PS) from the inner layer of the Ebola virus' membrane (envelope) to the outer layer. The exposed PS facilitates entry of the virus.

The researchers at Hokkaido University and the University of Tokyo generated Ebola virus-like particles by expressing viral proteins in cultured mammalian to investigate mechanisms by which Ebola virus enters cells. When the researchers disabled or blocked the activation of Xkr8, the exposure of PS on the surface of the virus particles was reduced.

First appearing in Sudan and the Democratic Republic of Congo in 1976, Ebola has instilled fear wherever infections have emerged due to its high fatality rate ranging from 25 percent to 90 percent. Most recently, west Africa experienced a record-breaking outbreak in 2014-2016. The virus spreads via the bodily fluids of infected animals and humans. Currently, there are no approved drugs for treating Ebola. Scientists are beginning to unravel how the virus works, which is critical for developing effective treatments.

The host enzyme Xkr8 is transported to the Ebola virus budding site along with viral glycoprotein(GP) and then incorporated to the viral envelope. Xkr8 flips PS from the inner layer to the outer layer of the envelope, exposing the phospholipids, which contribute to viral infection. VP40 is a major structural protein of the virus. Credit: Nanbo A. et al., PLoS Pathogens, January 16, 2018

In Ebola virus-infected cells, the viral components replicate and assemble to generate progeny viruses. The progeny viruses bud from the surface of host cells, acquiring an envelope derived from the host's cell surface membrane.

The team from Hokkaido University and elsewhere have demonstrated that the Ebola virus enters the target cells through the interaction between glycoprotein (GP) on the virus' surface and its receptor on the cell surface. In addition to GP, PS in virus envelope has been shown to facilitate entry of the Ebola virus. To be recognized by the target cells, PS needs to be present on the surface of the . However, PS is typically found on the inner side of membranes and it has been unknown how PS changes its location in the virus envelope.

The researchers have found that Xkr8 is transported to the budding site along with GP, and incorporated into the envelope. Xkr8 is then activated, which leads to exposure of PS on its surface so the virus can enter the .

Associate Professor Asuka Nanbo of the research team at Hokkaido University says, "PS is known to function in the entry process of various pathogenic viruses. So, we expect this pathway provides a potential target for developing new drugs against those viruses as well as the Ebola ."

Explore further: Researchers inhibit Ebola virus

More information: Asuka Nanbo et al, Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles, PLOS Pathogens (2018). DOI: 10.1371/journal.ppat.1006848

Related Stories

Researchers inhibit Ebola virus

December 29, 2017
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus ...

Silence is golden—Suppressing host response to Ebola virus may help to control infection

March 22, 2017
The Ebola virus causes a severe, often fatal illness when it infects the human body. Initially targeting cells of the immune system called macrophages, white blood cells that absorb and clear away pathogens, a new study has ...

Super cell to contain deadly Ebola virus discovered in Australia

July 18, 2017
A super cell in the eye has been discovered that can stop the deadly Ebola virus.

Researchers identify novel way to target Ebola

September 26, 2017
Researchers have identified a potential new way to attack Ebola. Scientists have discovered that a protein called Tim-1 (T-cell immunoglobulin and mucin domain-containing protein 1) plays a key role in the development of ...

Researchers find possible explanation for unparalleled spread of Ebola virus

June 7, 2017
The world may be closer to knowing why Ebola spreads so easily thanks to a team of researchers from Tulane University and other leading institutions who discovered a new biological activity in a small protein from the deadly ...

Recommended for you

Reconstructing Zika's spread

May 24, 2018
The urgent threat from Zika virus, which dominated news headlines in the spring and summer of 2016, has passed for now. But research into how Zika and other mosquito-borne infections spread and cause epidemics is still very ...

Tick bite protection: New CDC study adds to the promise of permethrin-treated clothing

May 24, 2018
The case for permethrin-treated clothing to prevent tick bites keeps getting stronger.

Early lactate measurements appear to improve results for septic patients

May 24, 2018
On October 1, 2015, the United States Centers for Medicare and Medicaid Services (CMS) issued a bundle of recommendations defining optimal treatment of patients suffering from sepsis, a life-threatening response to infection ...

Dengue: Investigating antibodies to identify at-risk individuals

May 23, 2018
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus ...

Fatty liver disease research set to benefit from stem cell advance

May 23, 2018
Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

More frequent checks control MRSA in newborns, but can hospitals afford them?

May 22, 2018
The more often a hospital can check its newborns for deadly MRSA germs, the more likely it will be that they are contained, according to a new study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.